134 related articles for article (PubMed ID: 24460515)
1. Dry Eye Syndrome in Non-Exophthalmic Graves' Disease.
Bruscolini A; Abbouda A; Locuratolo N; Restivo L; Trimboli P; Romanelli F
Semin Ophthalmol; 2015; 30(5-6):372-6. PubMed ID: 24460515
[TBL] [Abstract][Full Text] [Related]
2. Impact of Graves Disease on Ocular Surface and Corneal Epithelial Thickness in Patients With and Without Graves Orbitopathy.
Carreira AR; Rodrigues-Barros S; Moraes F; Loureiro T; Machado I; Campos P; Nobre Cardoso J; Campos N
Cornea; 2022 Apr; 41(4):443-449. PubMed ID: 34029245
[TBL] [Abstract][Full Text] [Related]
3. Ocular surface and dry eye in Graves' disease.
Gürdal C; Saraç O; Genç I; Kırımlıoğlu H; Takmaz T; Can I
Curr Eye Res; 2011 Jan; 36(1):8-13. PubMed ID: 21174592
[TBL] [Abstract][Full Text] [Related]
4. Dry eye in Graves ophthalmopathy: correlation with corneal hypoesthesia.
Achtsidis V; Tentolouris N; Theodoropoulou S; Panagiotidis D; Vaikoussis E; Saldana M; Gouws P; Theodossiadis PG
Eur J Ophthalmol; 2013; 23(4):473-9. PubMed ID: 23483512
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.
Sawicka-Gutaj N; Budny B; Zybek-Kocik A; Sowiński J; Ziemnicka K; Waligórska-Stachura J; Ruchała M
Endocrine; 2016 Aug; 53(2):497-504. PubMed ID: 26767650
[TBL] [Abstract][Full Text] [Related]
6. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.
Kashkouli MB; Alemzadeh SA; Aghaei H; Pakdel F; Abdolalizadeh P; Ghazizadeh M; Moradpasandi F
Ocul Surf; 2018 Oct; 16(4):458-462. PubMed ID: 30297028
[TBL] [Abstract][Full Text] [Related]
7. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
[TBL] [Abstract][Full Text] [Related]
8. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
[TBL] [Abstract][Full Text] [Related]
9. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome.
Le Q; Ge L; Li M; Wu L; Xu J; Hong J; Gong L
Acta Ophthalmol; 2014 Mar; 92(2):e124-32. PubMed ID: 23901943
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
11. Corneal involvement in Graves' orbitopathy: an in vivo confocal study.
Villani E; Viola F; Sala R; Salvi M; Mapelli C; Currò N; Vannucchi G; Beck-Peccoz P; Ratiglia R
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4574-8. PubMed ID: 20435595
[TBL] [Abstract][Full Text] [Related]
12. Ocular Surface Alterations and In Vivo Confocal Microscopic Features of Corneas in Patients With Newly Diagnosed Graves' Disease.
Kocabeyoglu S; Mocan MC; Cevik Y; Irkec M
Cornea; 2015 Jul; 34(7):745-9. PubMed ID: 25811727
[TBL] [Abstract][Full Text] [Related]
13. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.
Ujhelyi B; Gogolak P; Erdei A; Nagy V; Balazs E; Rajnavolgyi E; Berta A; Nagy EV
Thyroid; 2012 Apr; 22(4):407-14. PubMed ID: 22385289
[TBL] [Abstract][Full Text] [Related]
14. Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule.
Regalbuto C; Le Moli R; Muscia V; Russo M; Vigneri R; Pezzino V
Thyroid; 2012 Feb; 22(2):210-3. PubMed ID: 22196093
[TBL] [Abstract][Full Text] [Related]
15. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Bossowski A; Stasiak-Barmuta A; Urban M
Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
[TBL] [Abstract][Full Text] [Related]
16. Pure eye muscle involvement in endocrine orbitopathy.
Gerlach M; Ferbert A
Eur Neurol; 2008; 60(2):67-72. PubMed ID: 18480610
[TBL] [Abstract][Full Text] [Related]
17. [Tear film profile in patients with active thyroid orbithopathy].
Nowak M; Marek B; Kos-Kudła B; Kajdaniuk D; Siemińska L
Klin Oczna; 2005; 107(7-9):479-82. PubMed ID: 16417002
[TBL] [Abstract][Full Text] [Related]
18. Tear film profile in Graves' ophthalmopathy.
Khurana AK; Sunder S; Ahluwalia BK; Malhotra KC
Acta Ophthalmol (Copenh); 1992 Jun; 70(3):346-9. PubMed ID: 1636395
[TBL] [Abstract][Full Text] [Related]
19. Meibomian gland dysfunction in Graves' orbitopathy.
Kim YS; Kwak AY; Lee SY; Yoon JS; Jang SY
Can J Ophthalmol; 2015 Aug; 50(4):278-82. PubMed ID: 26257221
[TBL] [Abstract][Full Text] [Related]
20. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK.
Denoyer A; Landman E; Trinh L; Faure JF; Auclin F; Baudouin C
Ophthalmology; 2015 Apr; 122(4):669-76. PubMed ID: 25458707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
